Mohamad Shebley Selected Research

Neoplasms (Cancer)

1/2021	Mechanistic Modeling of Intra-Tumor Spatial Distribution of Antibody-Drug Conjugates: Insights into Dosing Strategies in Oncology.
9/2018	Accelerating drug development in pediatric cancer: a novel Phase I study design of venetoclax in relapsed/refractory malignancies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mohamad Shebley Research Topics

Disease

9	Endometriosis 04/2024 - 01/2020
9	Pain (Aches) 04/2024 - 01/2016
7	Leiomyoma (Uterine Fibroids) 04/2024 - 12/2020
6	Menorrhagia 04/2024 - 12/2020
2	Migraine Disorders (Migraine) 01/2024 - 01/2024
2	Neoplasms (Cancer) 01/2021 - 09/2018
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2017
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 09/2018 - 01/2017
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 06/2023
1	COVID-19 01/2023
1	Osteoporotic Fractures 12/2022
1	Bone Fractures (Bone Fracture) 12/2022
1	Body Weight (Weight, Body) 01/2022
1	Pelvic Pain 10/2021
1	Bone Resorption 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 09/2018
1	Neuralgia (Stump Neuralgia) 01/2016

Drug/Important Bio-Agent (IBA)

12	elagolixIBA 04/2024 - 01/2020
6	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 04/2024 - 01/2020
4	Estradiol (Delestrogen)FDA LinkGeneric 01/2023 - 12/2020
4	Norethindrone Acetate (Norlutate)FDA LinkGeneric 01/2023 - 12/2020
3	Monoclonal AntibodiesIBA 01/2024 - 01/2023
2	TabletsIBA 04/2024 - 01/2023
2	Calcitonin Gene-Related PeptideIBA 01/2024 - 01/2024
2	Calcitonin Gene-Related Peptide Receptor AntagonistsIBA 01/2024 - 01/2024
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 06/2023 - 10/2021
2	Peptides (Polypeptides)IBA 01/2022 - 01/2017
2	AnionsIBA 01/2022 - 01/2017
2	venetoclaxIBA 09/2018 - 01/2017
2	Cytochrome P-450 CYP3AIBA 01/2017 - 01/2017
1	Capsules (Microcapsules)IBA 04/2024
1	ubrogepantIBA 01/2024
1	atogepantIBA 01/2024
1	LigandsIBA 01/2024
1	Antiviral Agents (Antivirals)IBA 01/2023
1	linzagolixIBA 10/2021
1	relugolixIBA 10/2021
1	opigolixIBA 10/2021
1	CalciumIBA 01/2021
1	ProcollagenIBA 01/2021
1	Collagen Type I (Type I Collagen)IBA 01/2021
1	Cytotoxins (Cytolysins)IBA 01/2021
1	Immunoconjugates (Immunoconjugate)IBA 01/2021
1	Ado-Trastuzumab EmtansineIBA 01/2021
1	Hormones (Hormone)IBA 01/2020
1	GonadotropinsIBA 01/2020
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 01/2017
1	Ketoconazole (Nizoral)FDA LinkGeneric 01/2017
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2017
1	Cytochrome P-450 CYP3A InhibitorsIBA 01/2017
1	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 01/2017
1	Cytochrome P-450 CYP2C8IBA 01/2017
1	Reserpine (Serpasil)FDA Link 01/2016

Therapy/Procedure

5	Therapeutics 01/2024 - 10/2021
1	Intravenous Infusions 01/2023
1	Duration of Therapy 01/2021
1	Drug Therapy (Chemotherapy) 09/2018